Please Wait
Applying Filters...
Menu
$ API Ref.Price (USD/KG) : 58,884Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 3Supriya Lifescience

02 6ZOETIS MANUFACTURING ITALIA S.R.L. IT 95121 Catania

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass

01

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothSupriya Lifesciences is a cGMP-compliant API manufacturing organization with a leadership position across key & niche products.

Regulatory Info :

Registration Country : India

Oclacitinib Maleate

Brand Name :

Dosage Form : Tablet

Dosage Strength : 3.6MG

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : India

Supriya

02

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothSupriya Lifesciences is a cGMP-compliant API manufacturing organization with a leadership position across key & niche products.

Regulatory Info :

Registration Country : India

Oclacitinib Maleate

Brand Name :

Dosage Form : Tablet

Dosage Strength : 5.4MG

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : India

Supriya

03

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothSupriya Lifesciences is a cGMP-compliant API manufacturing organization with a leadership position across key & niche products.

Regulatory Info :

Registration Country : India

Oclacitinib Maleate

Brand Name :

Dosage Form : Tablet

Dosage Strength : 16MG

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : India

Supriya

04

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

OCLACITINIB (OCLACITINIB MALEATE)

Brand Name : APOQUEL

Dosage Form : TABLET

Dosage Strength : 3.6MG

Packaging : 100

Approval Date :

Application Number : 2427885

Regulatory Info : Prescription

Registration Country : Canada

blank

05

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

OCLACITINIB (OCLACITINIB MALEATE)

Brand Name : APOQUEL

Dosage Form : TABLET

Dosage Strength : 5.4MG

Packaging :

Approval Date :

Application Number : 2427893

Regulatory Info : Prescription

Registration Country : Canada

blank

06

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

OCLACITINIB (OCLACITINIB MALEATE)

Brand Name : APOQUEL

Dosage Form : TABLET

Dosage Strength : 16MG

Packaging :

Approval Date :

Application Number : 2427907

Regulatory Info : Prescription

Registration Country : Canada

blank

07

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

OCLACITINIB (OCLACITINIB MALEATE)

Brand Name : APOQUEL

Dosage Form : TABLET (CHEWABLE)

Dosage Strength : 3.6MG

Packaging :

Approval Date :

Application Number : 2530651

Regulatory Info : Prescription

Registration Country : Canada

blank

08

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

OCLACITINIB (OCLACITINIB MALEATE)

Brand Name : APOQUEL

Dosage Form : TABLET (CHEWABLE)

Dosage Strength : 5.4MG

Packaging :

Approval Date :

Application Number : 2530678

Regulatory Info : Prescription

Registration Country : Canada

blank

09

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

OCLACITINIB (OCLACITINIB MALEATE)

Brand Name : APOQUEL

Dosage Form : TABLET (CHEWABLE)

Dosage Strength : 16MG

Packaging :

Approval Date :

Application Number : 2530686

Regulatory Info : Prescription

Registration Country : Canada

blank